tRNA‐derived fragment tRF‐30 propels diabetes‐induced retinal microvascular complications by regulating STAT3 signaling.

Transfer RNA‐derived fragments (tRFs) represent a novel class of non‐coding RNA transcripts that possess specific biological functions. However, the involvement of tRFs in retinal microvascular diseases remains poorly understood. In this study, we aimed to reveal whether modulation of tRF‐30 expression could attenuate pathological retinal neovascular diseases. Our findings demonstrate a significant upregulation of tRF‐30 expression levels in both in vivo models of diabetic retinopathy (DR) and in vitro endothelial sprouting models. Conversely, inhibition of tRF‐30 expression suppressed the formation of abnormal neovascularization in the retina in vivo, while reducing the proliferation and migration activity of retinal vascular endothelial cells in vitro. We also found that tRF‐30 modulates retinal neovascularization through the tRF‐30/TRIB3/signal transducer and activated transcription 3 signaling pathway. Furthermore, we validated a significant upregulation of tRF‐30 expression levels in the vitreous humor of DR patients, with high levels of both validity and specificity in diagnostic testing. Collectively, our findings highlight a pro‐angiogenic role for tRF‐30 in DR. Intervening in the tRF‐30 signaling pathway may represent a promising prevention and treatment strategy for retinal angiogenesis. [ABSTRACT FROM AUTHOR]